AI in Oncology: Current and Future Applications
AI has been used in oncology for years, but recent studies suggest AI could have many additional applications in cancer care.
AI has been used in oncology for years, but recent studies suggest AI could have many additional applications in cancer care.
Researchers say they have identified adverse events that are more likely to occur in cancer patients receiving antibody-drug conjugates.
Researchers have found several differences in cancer rates between members of the US military and the general US population.
Higher exposure to PFAS, phenols, and parabens is associated with previous cancer diagnosis in women but not men, a study suggests.
Adding HIPEC to interval cytoreductive surgery improves long-term outcomes in stage III epithelial ovarian cancer, a phase 3 trial suggests.
The US supply of cisplatin is nearly restored, and shortages of carboplatin and methotrexate have been alleviated, the government says.
A meta-analysis suggests that ranitidine does not pose an increased risk of cancer when compared to other histamine-2 receptor antagonists.
Pembrolizumab plus chemoradiotherapy is under priority review for newly diagnosed, high-risk, locally advanced cervical cancer.
Mississippi had the nation’s second-highest age-adjusted cervical cancer mortality rate from 2016 through 2020.
Adding atezolizumab to bevacizumab and platinum-based chemotherapy did not improve PFS in recurrent, platinum-sensitive ovarian cancer.